Journey Medical Corporation (DERM)

Journey Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.07	20.31	27.44	32	49.08	8.25
Cash & Short-Term Investments	21.07	20.31	27.44	32	49.08	8.25
Cash Growth	-12.42%	-26.00%	-14.26%	-34.80%	495.21%	71.76%
Receivables	18.03	10.23	15.22	28.21	23.11	23.93
Inventory	12.5	14.43	10.21	14.16	9.86	1.4
Prepaid Expenses	2.4	3.21	3.59	3.31	2.44	1.66
Total Current Assets	53.99	48.18	56.46	77.68	84.49	35.24
Property, Plant & Equipment	0.18	0.2	0.1	0.19	0.09	0.18
Other Intangible Assets	30.8	31.86	20.29	27.2	12.55	15.03
Long-Term Deferred Tax Assets	-	-	-	-	-	1.45
Other Long-Term Assets	-	-	0.01	0.1	0.15	0.01
Total Assets	84.96	80.24	76.85	105.16	97.28	51.91
Accounts Payable	14.4	16.05	18.15	36.57	22.81	1.86
Accrued Expenses	23.39	15.23	16.49	16.27	20.09	19.02
Short-Term Debt	1.88	-	-	2.95	0.81	-
Current Portion of Long-Term Debt	-	0.63	3	2.24	4.51	4.52
Current Portion of Leases	0.09	0.08	0.1	0.08	0.1	0.09
Current Income Taxes Payable	0.06	0.06	0.05	0.04	0.01	-
Other Current Liabilities	0.4	3.12	4.08	8.68	3.28	2.58
Total Current Liabilities	40.22	35.18	41.87	66.83	51.61	28.06
Long-Term Debt	23.11	24.88	14.62	21.24	3.63	13.36
Long-Term Leases	0.09	0.12	0.01	0.11	-	0.1
Other Long-Term Liabilities	-	-	-	-	-	0.1
Total Liabilities	63.42	60.17	56.5	88.18	55.24	41.61
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	112.64	107.09	92.7	85.48	80.92	5.17
Retained Earnings	-91.1	-87.03	-72.36	-68.5	-38.87	5.12
Shareholders' Equity	21.54	20.07	20.35	16.98	42.04	10.29
Total Liabilities & Equity	84.96	80.24	76.85	105.16	97.28	51.91
Total Debt	25.17	25.71	17.73	26.62	9.05	18.06
Net Cash (Debt)	-4.1	-5.4	9.71	5.38	40.03	-9.82
Net Cash Growth	-	-	80.40%	-86.56%	-	-
Net Cash Per Share	-0.19	-0.26	0.53	0.31	3.93	-0.91
Filing Date Shares Outstanding	23.3	23.1	19.93	17.83	17.32	9.15
Total Common Shares Outstanding	23.1	22.15	19.32	17.77	17.32	9.15
Working Capital	13.76	13	14.59	10.85	32.88	7.18
Book Value Per Share	0.93	0.91	1.05	0.96	2.43	1.12
Tangible Book Value	-9.26	-11.79	0.06	-10.22	29.49	-4.74
Tangible Book Value Per Share	-0.40	-0.53	0.00	-0.57	1.70	-0.52

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q